Dr. Heinrich Taegtmeyer received his medical degree from the Albert Ludwig University of Freiburg Faculty of Medicine in Freiburg im Breisgau, Germany. He completed his internship, residency and fellowship at Harvard Medical School in Boston, Mass.
Board certified in both internal medicine and cardiovascular disease, Dr. Taegtmeyer specializes in cardiology (consultative and outpatient), cardiovascular diseases, diabetes, electrocardiography, heart failure and obesity.
Dr. Taegtmeyer is a member of the Alpha Omega Alpha, and is a fellow of the American Heart Association (AHA), the American College of Cardiology (ACC), the American College of Physicians (ACP) and the International Academy of Cardiovascular Sciences (IACS). He served as president of the Society for Heart and Vascular Metabolism (SHCM) from 2006 to 2009. In addition, Dr. Taegtmeyer has supervised 12 graduate students and 16 postdoctoral fellows, and he has mentored 15 medical or surgical residents on research rotations as well as 43 summer students. Many of his students hold academic appointments in the United States and Germany.
Dr. Taegtmeyer was a full member of the National Institutes of Health (NIH) Metabolism Study Section from 1989 to 1993 and has since served as an ad hoc member of various NIH study sections on a yearly basis. In 2005 the Director of the National Heart, Lung, and Blood Institute (NHLBI) named Dr. Taegtmeyer to the NIH Protocol Review Committee for the IMMEDIATE Trial, a double-blind randomized controlled trial of intravenous glucose, insulin and potassium for acute coronary syndromes in emergency medical services. In 2006 he was named to the NHLBI Data Safety Monitoring Board for the IMMEDIATE Trial. He has served on the Scientific Advisory Committee of the University Clinical Research Center since 1995, and on the MacDonald Fund Research Committee since 2007.